|
1
|
Chen JC, Chiu MH, Nie RL, Cordell GA and
Qiu SX: Cucurbitacins and cucurbitane glycosides: Structures and
biological activities. Nat Prod Rep. 22:386–399. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ishii T, Kira N, Yoshida T and Narahara H:
Cucurbitacin D induces growth inhibition, cell cycle arrest, and
apoptosis in human endometrial and ovarian cancer cells. Tumour
Biol. 34:285–291. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kapoor S: Cucurbitacin B and its rapidly
emerging role in the management of systemic malignancies besides
lung carcinomas. Cancer Biother Radiopharm. 28:3592013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lui VW, Yau DM, Wong EY, Ng YK, Lau CP, Ho
Y, Chan JP, Hong B, Ho K, Cheung CS, et al: Cucurbitacin I elicits
anoikis sensitization, inhibits cellular invasion and in vivo tumor
formation ability of nasopharyngeal carcinoma cells.
Carcinogenesis. 30:2085–2094. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cadron I, Van Gorp T, Amant F, Leunen K,
Neven P and Vergote I: Chemotherapy for recurrent cervical cancer.
Gynecol Onco. 107(1 Suppl 1): S113–S118. 2007. View Article : Google Scholar
|
|
7
|
Engelman JA: Targeting PI3K signalling in
cancer: Opportunities, challenges and limitations. Nat Rev Cancer.
9:550–562. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Romashkova JA and Makarov SS: NF-kappaB is
a target of AKT in anti-apoptotic PDGF signalling. Nature.
401:86–90. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chiang JH, Yang JS, Ma CY, Yang MD, Huang
HY, Hsia TC, Kuo HM, Wu PP, Lee TH and Chung JG: Danthron, an
anthraquinone derivative, induces DNA damage and caspase
cascades-mediated apoptosis in SNU-1 human gastric cancer cells
through mitochondrial permeability transition pores and
Bax-triggered pathways. Chem Res Toxicol. 24:20–29. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sun SY, Hail N Jr and Lotan R: Apoptosis
as a novel target for cancer chemoprevention. J Natl Cancer Inst.
96:662–672. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Maitra R, Porter MA, Huang S and Gilmour
BP: Inhibition of NFkappaB by the natural product Withaferin A in
cellular models of Cystic Fibrosis inflammation. J Inflamm (Lond).
6:152009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chiang LC, Ng LT, Lin IC, Kuo PL and Lin
CC: Anti-proliferative effect of apigenin and its apoptotic
induction in human Hep G2 cells. Cancer Lett. 237:207–214. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ren S, Ouyang DY, Saltis M, Xu LH, Zha QB,
Cai JY and He XH: Anti-proliferative effect of
23,24-dihydrocucurbitacin F on human prostate cancer cells through
induction of actin aggregation and cofilin-actin rod formation.
Cancer Chemother Pharmacol. 70:415–424. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang L, Wu S, Zhang Q, Liu F and Wu P:
23,24-Dihydrocucurbitacin B induces G2/M cell-cycle arrest and
mitochondria-dependent apoptosis in human breast cancer cells
(Bcap37). Cancer Lett. 256:267–278. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hissin PJ and Hilf R: A fluorometric
method for determination of oxidized and reduced glutathione in
tissues. Anal Biochem. 74:214–226. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chipuk JE, Bouchier-Hayes L and Green DR:
Mitochondrial outer membrane permeabilization during apoptosis: The
innocent bystander scenario. Cell Death Diff. 13:1396–1402. 2006.
View Article : Google Scholar
|
|
17
|
Azuma M, Tamatani T, Ashida Y, Takashima
R, Harada K and Sato M: Cisplatin induces apoptosis in oral
squamous carcinoma cells by the mitochondria-mediated but not the
NF-kappaB-suppressed pathway. Oral Oncol. 39:282–289. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yoneda K, Yamamoto T and Osaki T: p53- and
p21-independent apoptosis of squamous cell carcinoma cells induced
by 5-fluorouracil and radiation. Oral Oncol. 34:529–537. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Abal M, Andreu JM and Barasoain I:
Taxanes: Microtubule and centrosome targets and cell cycle
dependent mechanisms of action. Curr Canc Drug Targs. 3:193–203.
2003. View Article : Google Scholar
|
|
20
|
Ferreira CG, Epping M, Kruyt FA and
Giaccone G: Apoptosis: Target of cancer therapy. Clin Cancer Res.
8:2024–2034. 2002.PubMed/NCBI
|
|
21
|
Indran IR, Hande MP and Pervaiz S: hTERT
overexpression alleviates intracellular ROS production, improves
mitochondrial function, and inhibits ROS-mediated apoptosis in
cancer cells. Cancer Res. 71:266–276. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sharma V, Anderson D and Dhawan A: Zinc
oxide nanoparticles induce oxidative DNA damage and ROS-triggered
mitochondria mediated apoptosis in human liver cells (HepG2).
Apoptosis. 17:852–870. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li AX, Sun M and Li X: Withaferin-A
induces apoptosis in osteosarcoma U2OS cell line via generation of
ROS and disruption of mitochondrial membrane potential. Eur Rev Med
Pharmacol Sci. 21:1368–1374. 2017.PubMed/NCBI
|
|
24
|
Sun H, Wang Z and Sebastian Yakisich J:
Natural products targeting autophagy via the PI3K/Akt/mTOR pathway
as anticancer agents. Anticancer Agents Med Chem. 13:1048–1056.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Matsuda S, Ichimura M, Ogino M, Nakano N,
Minami A, Murai T and Kitagishi Y: Effective PI3K modulators for
improved therapy against malignant tumors and for neuroprotection
of brain damage after tumor therapy (Review). Int J Oncol.
49:1785–1790. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Caporali S, Alvino E, Lacal PM, Levati L,
Giurato G, Memoli D, Caprini E, Antonini Cappellini GC and D'atri
S: Targeting the PI3K/AKT/mTOR pathway overcomes the stimulating
effect of dabrafenib on the invasive behavior of melanoma cells
with acquired resistance to the BRAF inhibitor. Int J Oncol.
49:1164–1174. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Blair J, Barry R, Moore DJ and Denniston
AK: A comprehensive review of mTOR-inhibiting pharmacotherapy for
the treatment of non-infectious uveitis. Curr Pharm Des.
23:3005–3014. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nicoletti F, Fagone P, Meroni P, McCubrey
J and Bendtzen K: mTOR as a multifunctional therapeutic target in
HIV infection. Drug Discov Today. 16:715–721. 2011. View Article : Google Scholar : PubMed/NCBI
|
